MyJournals Home  

RSS FeedsComparative effectiveness research on patients with acute ischemic stroke using Markov decision processes (BMC Medical Research Methodology)

 
 

9 march 2012 09:36:30

 
Comparative effectiveness research on patients with acute ischemic stroke using Markov decision processes (BMC Medical Research Methodology)
 


Background: Several methodological issues with non-randomized comparative clinical studies have been raised, one of which is whether the methods used can adequately identify uncertainties that evolve dynamically with time in real-world systems. The objective of this study is to compare the effectiveness of different combinations of Traditional Chinese Medicine (TCM) treatments and combinations of TCM and Western medicine interventions in patients with acute ischemic stroke (AIS) by using Markov decision process (MDP) theory. MDP theory appears to be a promising new method for use in comparative effectiveness research. Methods: The electronic health records (EHR) of patients with AIS hospitalized at the 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine between May 2005 and July 2008 were collected. Each record was portioned into two `state-action-reward` stages divided by three time points: the first, third, and last day of hospital stay. We used the well-developed optimality technique in MDP theory with the finite horizon criterion to make the dynamic comparison of different treatment combinations. Results: A total of 1504 records with a primary diagnosis of AIS were identified. Only states with more than 10 (including 10) patients` information were included, which gave 960 records to be enrolled in the MDP model. Optimal combinations were obtained for 30 types of patient condition. Conclusion: MDP theory makes it possible to dynamically compare the effectiveness of different combinations of treatments. However, the optimal interventions obtained by the MDP theory here require further validation in clinical practice. Further exploratory studies with MDP theory in other areas in which complex interventions are common would be worthwhile.


 
306 viewsCategory: Medicine
 
Advances in using PARP inhibitors to treat cancer (BMC Medicine)
Is interleukin-6 an appropriate target to treat spondyloarthritis patients refractory to anti-tnf therapy? A cross-sectional national survey. (Arthritis Research & Therapy)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Medicine


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten